Alterity Therapeutics (ATHE) Depreciation & Amortization - Total (2014 - 2015)
Alterity Therapeutics (ATHE) posted quarterly Depreciation & Amortization - Total of -$18372.2 for Q4 2015, up 36.45% year-over-year from -$13464.6 in Q4 2014, and up 36.45% quarter-over-quarter from -$28909.5 in Q4 2014.
Alterity Therapeutics (ATHE) Depreciation & Amortization - Total (2014 - 2015) Analysis & Trends
Alterity Therapeutics' Depreciation & Amortization - Total history runs 2 years deep, the most recent figure standing at -$18372.2 for Q4 2015.
- In Q4 2015, Depreciation & Amortization - Total rose 36.45% year-over-year to -$18372.2; the TTM figure through Jun 2017 stood at -$18372.2 (up 61.14% YoY), while the FY2015 annual figure was $26454.1, up 228.71% from the prior year.
- Depreciation & Amortization - Total for Q4 2015 stood at -$18372.2, up from -$28909.5 in the prior quarter.
- The five-year high for Depreciation & Amortization - Total was -$18372.2 in Q4 2015, with the low at -$28909.5 in Q4 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dep. & Amort. (Tot) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Alterity Therapeutics | 48.56 Mn | 16.26 Mn | - | -73,230.50 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2015 | -18,372.25 |
| Dec 31, 2014 | -28,909.45 |